TABLE 3.
Year | No. of patients | Analysis model(s) | Association with PNI | Prognosis significance | P value/OR | Reference(s) |
---|---|---|---|---|---|---|
1996 | 113 (69.9%) |
Kaplan‐Meier analysis; Cox proportional hazards analysis |
Negative | Not an independent risk factor | 0.01 | [98] |
2002 | 24 (70.8%) |
Kaplan‐Meier analysis; Cox proportional hazards analysis |
Negative | NA | NA | [99] |
2006 | 56 (NA) |
Kaplan‐Meier analysis; Cox proportional hazards analysis |
Negative | Prognostic parameters | < 0.01 | [19] |
2007 | 33 (57.6%) | Kaplan‐Meier analysis | Negative | NA | 0.023 | [100] |
2007 | 75 (65.3%) |
Kaplan‐Meier analysis; Cox proportional hazards analysis |
Negative | Prognostic parameters | 0.034 | [10] |
2010 | 96 (53.1%) | Log‐rank test; Cox multi‐regression analysis | Negative | Prognostic parameters | 0.0001 | [101] |
2011 | 95 (88.0%) | Kaplan‐Meier analysis; univariate and multivariate Cox regression analysis | Negative | NA | 0.02 | [140] |
2012 | 212 (58%) |
Kaplan‐Meier analysis; Cox regression analysis; Cox proportional hazards models |
Negative | NA | 0.03 | [108] |
2015 | 209 (94%) |
Kaplan‐Meier analysis; Cox proportional hazards analysis |
Negative | Prognostic parameters | 0.0001 | [104] |
2016 | 173 (60.7%) | Multivariate Logistic Regression | Negative | Absence of PNI is independently associated with increased odds of long‐term survival | 0.036 | [106] |
2016 | 59 (50.8%) | Kaplan‐Meier analysis; multivariate Cox regression analysis | Negative | Prognostic parameters | 0.0009 | [109] |
2017 | 3538 (76.2‐97.8%) | Meta‐analysis | Negative | Prognostic parameters | < 0.00001 | [141] |
2019 | 17,313 (NA) | Meta‐analysis | Negative | Risk factors for recurrence | OR: 5·19, 2·79 to 9·64 | [110] |
2020 | 778 (87%) | Kaplan‐Meier analysis; multivariable Cox proportional hazards models | Negative | Prognostic parameters | 0.01 | [102] |
2020 | 400 (87.7%) | Kaplan‐Meier analysis; univariate and multivariate Cox regression analysis | Negative | Prognostic parameters | 0.05 | [103] |